210 related articles for article (PubMed ID: 28738876)
21. Structural determinants of plant lignans for the formation of enterolactone in vivo.
Saarinen NM; Smeds A; Mäkelä SI; Ammälä J; Hakala K; Pihlava JM; Ryhänen EL; Sjöholm R; Santti R
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Sep; 777(1-2):311-9. PubMed ID: 12270222
[TBL] [Abstract][Full Text] [Related]
22. Genistein and enterolactone in relation to Ki-67 expression and HER2 status in postmenopausal breast cancer patients.
Jaskulski S; Jung AY; Rudolph A; Johnson T; Thöne K; Herpel E; Sinn P; Chang-Claude J
Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28734033
[TBL] [Abstract][Full Text] [Related]
23. Enterodiol and enterolactone, two major diet-derived polyphenol metabolites have different impact on ERalpha transcriptional activation in human breast cancer cells.
Carreau C; Flouriot G; Bennetau-Pelissero C; Potier M
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):176-85. PubMed ID: 18457947
[TBL] [Abstract][Full Text] [Related]
24. Dietary lariciresinol attenuates mammary tumor growth and reduces blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.
Saarinen NM; Wärri A; Dings RP; Airio M; Smeds AI; Mäkelä S
Int J Cancer; 2008 Sep; 123(5):1196-204. PubMed ID: 18528864
[TBL] [Abstract][Full Text] [Related]
25. The effect of enterolactone on sphingolipid pathway and hepatic insulin resistance development in HepG2 cells.
Charytoniuk T; Iłowska N; Berk K; Drygalski K; Chabowski A; Konstantynowicz-Nowicka K
Life Sci; 2019 Jan; 217():1-7. PubMed ID: 30468835
[TBL] [Abstract][Full Text] [Related]
26. Relation between plasma enterodiol and enterolactone and dietary intake of lignans in a Dutch endoscopy-based population.
Milder IE; Kuijsten A; Arts IC; Feskens EJ; Kampman E; Hollman PC; Van 't Veer P
J Nutr; 2007 May; 137(5):1266-71. PubMed ID: 17449591
[TBL] [Abstract][Full Text] [Related]
27. Effects of metabolites of the lignans enterolactone and enterodiol on osteoblastic differentiation of MG-63 cells.
Feng J; Shi Z; Ye Z
Biol Pharm Bull; 2008 Jun; 31(6):1067-70. PubMed ID: 18520031
[TBL] [Abstract][Full Text] [Related]
28. Suitability of a batch in vitro fermentation model using human faecal microbiota for prediction of conversion of flaxseed lignans to enterolactone with reference to an in vivo rat model.
Aura AM; Oikarinen S; Mutanen M; Heinonen SM; Adlercreutz HC; Virtanen H; Poutanen KS
Eur J Nutr; 2006 Feb; 45(1):45-51. PubMed ID: 15864408
[TBL] [Abstract][Full Text] [Related]
29. Enterolactone inhibits the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinomas in the rat.
Saarinen NM; Huovinen R; Wärri A; Mäkelä SI; Valentín-Blasini L; Sjöholm R; Ammälä J; Lehtilä R; Eckerman C; Collan YU; Santti RS
Mol Cancer Ther; 2002 Aug; 1(10):869-76. PubMed ID: 12492120
[TBL] [Abstract][Full Text] [Related]
30. Anticancer and antimetastatic potential of enterolactone: Clinical, preclinical and mechanistic perspectives.
Mali AV; Padhye SB; Anant S; Hegde MV; Kadam SS
Eur J Pharmacol; 2019 Jun; 852():107-124. PubMed ID: 30771348
[TBL] [Abstract][Full Text] [Related]
31. Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines.
Chikara S; Lindsey K; Borowicz P; Christofidou-Solomidou M; Reindl KM
BMC Complement Altern Med; 2017 Jan; 17(1):30. PubMed ID: 28068967
[TBL] [Abstract][Full Text] [Related]
32. Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells.
Brooks JD; Thompson LU
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):461-7. PubMed ID: 15876411
[TBL] [Abstract][Full Text] [Related]
33. Factors Explaining Interpersonal Variation in Plasma Enterolactone Concentrations in Humans.
Hålldin E; Eriksen AK; Brunius C; da Silva AB; Bronze M; Hanhineva K; Aura AM; Landberg R
Mol Nutr Food Res; 2019 Aug; 63(16):e1801159. PubMed ID: 30817848
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological Effects of Natural Components Against Ovarian Cancer and Mechanisms.
Liu H; Liu SL
Adv Exp Med Biol; 2021; 1330():55-73. PubMed ID: 34339030
[TBL] [Abstract][Full Text] [Related]
35. Anti-proliferative effects of physiological concentrations of enterolactone in models of prostate tumourigenesis.
McCann MJ; Rowland IR; Roy NC
Mol Nutr Food Res; 2013 Feb; 57(2):212-24. PubMed ID: 23148045
[TBL] [Abstract][Full Text] [Related]
36. Novel metabolites of the mammalian lignans enterolactone and enterodiol in human urine.
Jacobs E; Kulling SE; Metzler M
J Steroid Biochem Mol Biol; 1999 Mar; 68(5-6):211-8. PubMed ID: 10416836
[TBL] [Abstract][Full Text] [Related]
37. Chemopreventive actions by enterolactone and 13 VIOXX-related lactone derivatives in H295R human adrenocortical carcinoma cells.
van Duursen MB; Nijmeijer SM; Ruchirawat S; van den Berg M
Toxicol Lett; 2010 Feb; 192(3):271-7. PubMed ID: 19913079
[TBL] [Abstract][Full Text] [Related]
38. Effect of mammalian lignans on the growth of prostate cancer cell lines.
Lin X; Switzer BR; Demark-Wahnefried W
Anticancer Res; 2001; 21(6A):3995-9. PubMed ID: 11911282
[TBL] [Abstract][Full Text] [Related]
39. Metformin inhibits the development and metastasis of ovarian cancer.
Wu B; Li S; Sheng L; Zhu J; Gu L; Shen H; La D; Hambly BD; Bao S; Di W
Oncol Rep; 2012 Sep; 28(3):903-8. PubMed ID: 22752027
[TBL] [Abstract][Full Text] [Related]
40. Prenatal lignan exposures, pregnancy urine estrogen profiles and birth outcomes.
Tang R; Chen M; Zhou K; Chen D; Yu J; Hu W; Song L; Hang B; Wang X; Xia Y
Environ Pollut; 2015 Oct; 205():261-8. PubMed ID: 26093977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
